Overview
Epoch Biodesign, a London-based company, has raised $12 million in a funding round, increasing its total funding to over $50 million. The company focuses on enzymatic recycling technology that enables the recycling of nylon 6,6 without virgin feedstock, addressing complex waste streams. Key investors include Lululemon and Kompas VC. The funding will aid in global commercialization and strengthen partnerships across various industries, enhancing supply chain sustainability.
Products
Loading...
Recent Deals
Investors: Lululemon, Kompas VC
Epoch Biodesign, a London-based company, has raised $12 million in a funding round, increasing its total funding to over $50 million. The company focuses on enzymatic recycling technology that enables the recycling of nylon 6,6 without virgin feedstock, addressing complex waste streams. Key investors include Lululemon and Kompas VC. The funding will aid in global commercialization and strengthen partnerships across various industries, enhancing supply chain sustainability.